Grants and Contracts per year
Personal profile
Research Interests
Obesity-associated complications (chronic inflammation, insulin resistance, NAFLD), kidney injury and cancer.
Education/Academic qualification
Doctor of Philosophy, Peking Medical Col.
1997
Doctor of Medicine, Shanxi Medical College
1991
Fingerprint
Dive into the research topics where Shuxia Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
Role of SMPDL3B in Obesity-Associated Non-Alcoholic Fatty Liver Disease
Wang, S., COHEN, D., Lee, E., Nikolova-Karakashian, M. & Tong, S.
National Institute Diabetes & Digestive & Kidney
7/1/22 → 4/30/27
Project: Research project
-
COBRE: Center of Research on Obesity and Cardiovascular Disease Core D: Energy Balance
Wang, S., Cassis, L., Katz, W. & Zhou, C.
National Institute of General Medical Sciences
8/1/18 → 7/31/23
Project: Research project
-
COBRE: Center of Research on Obesity and Cardiovascular Disease
Cassis, L., Finlin, B., Katz, W., Pearson, K., Stanley, S., Thompson, K., Wang, S., Morris, A. & Zhou, C.
National Institute of General Medical Sciences
8/1/18 → 7/31/23
Project: Research project
-
COBRE Pilot: Endogenous Ligand for NR4A1 Orphan Nuclear Receptor and Systemic Metabolism
National Institute of General Medical Sciences
8/1/18 → 7/31/23
Project: Research project
-
Targeting Brown Fat for Aging-related Obesity and Type 2 Diabetes
Washington University in St. Louis
2/23/13 → 11/30/23
Project: Research project
-
Anti-CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non-alcoholic steatohepatitis models
Gwag, T., Ma, E., Zhou, C. & Wang, S., Apr 2022, In: Liver International. 42, 4, p. 829-841 13 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Absence of CD47 maintains brown fat thermogenic capacity and protects mice from aging-related obesity and metabolic disorder
Li, D., Gwag, T. & Wang, S., Oct 20 2021, In: Biochemical and Biophysical Research Communications. 575, p. 14-19 6 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Erratum: Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis (Journal of Hepatology (2019) 70(5) (930–940), (S0168827819300297), (10.1016/j.jhep.2018.12.038))
Gwag, T., Meng, Z., Sui, Y., Helsley, R. N., Park, S. H., Wang, S., Greenberg, R. N. & Zhou, C., Apr 2021, In: Journal of Hepatology. 74, 4, p. 1003-1004 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease
Gwag, T., Reddy Mooli, R. G., Li, D., Lee, S., Lee, E. Y. & Wang, S., Feb 2021, In: JHEP Reports. 3, 1, 100193.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
CD47 differentially regulates white and brown fat function
Norman-Burgdolf, H., Li, D., Sullivan, P. & Wang, S., Dec 16 2020, In: Biology Open. 9, 12, bio056747.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations